Table 1– Characteristics of the patients that developed sarcoidosis following haematopoietic stem cell transplantation (HSCT)
CharacteristicsCase 1 [3]Case 2 [4]Case 3 [5]Case 4 [5]Case 5 [5]Case 6 [5]Case 7 [6]Case 8 [6]Case 9 [7]Present case
Age years Sex34 Male36 Female51 Female50 Female47 Female48 Female45 Female51 Male55 Female64 Female
Family history of sarcoidosisWith the donorWith the donorNoneNoneNoneNoneNoneNoneNoneNone
Underlying diseaseNHLCMLCMLBreast cancerBreast cancerBreast cancerMDSMDSFLATL
Type of HSCTAllo, siblingAllo, siblingAlloAutoAutoAutoAllo, UDAllo, UDAllo, UDAllo, UD
Post-HSCT period months3216831201220616
Chimerism analysis of lymph nodesNot doneNot doneNot doneNot doneNot doneNot doneNot doneNot doneSTR-PCRFISH
  • NHL: non-Hodgkin's lymphoma; CML: chronic myeloid leukaemia; MDS: myelodysplastic syndrome; FL: follicular lymphoma; ATL: adult T-cell leukaemia; Allo: allogeneic; Auto: autologous; UD: unrelated-donor; STR-PCR: short tandem repeat based PCR; FISH: fluorescence in situ hybridisation.